Ibrutinib increases the risk of atrial fibrillation, potentially through inhibition of cardiac PI3K-Akt signaling Letter uri icon

authors

  • McMullen, Julie R
  • Boey, Esther JH
  • Ooi, Jenny YY
  • Seymour, John F
  • Keating, Michael J
  • Tam, Constantine S

publication date

  • December 11, 2014

has subject area

published in